The US Centers for Disease Control and Prevention (CDC) is moving away from universal vaccine recommendations, replacing them with a new emphasis on “shared clinical decisionmaking.” This shift, spearheaded under Health and Human Services Secretary Robert F. Kennedy Jr., has already altered the childhood immunization schedule, removing blanket endorsements for six vaccines in favor of individualized assessments.
The term shared clinical decisionmaking has become central to Kennedy’s administration’s approach. National Institutes of Health Director Jay Bhattacharya, who temporarily oversees the CDC, champions the idea. Surgeon General nominee Casey Means also invoked it during her Senate confirmation, framing it as a patient-centered approach to vaccination.
The core issue: while seemingly reasonable, this concept is being weaponized to undermine public health. It’s meant to be a conversation between doctors and patients about benefits and risks. Critics argue that the current administration is using it as a pretext to erode confidence in vaccines without outright banning them.
Jennifer Nuzzo, an epidemiologist at Brown University, points out that the scientific consensus on vaccine safety and efficacy is firm. “Labeling them as something that requires shared clinical decisionmaking implies uncertainty where none exists.”
The CDC first applied this approach to Covid-19 vaccines in May 2023, suggesting parental discussion before vaccinating children aged 6 months to 17 years. Later, Kennedy’s advisory committee overruled prior guidance for annual Covid boosters, again favoring individualized assessments. In January 2024, the CDC dropped universal recommendations for hepatitis A, B, influenza, meningococcal ACWY, and rotavirus, relegating them to the “shared clinical decisionmaking” category. Crucially, these changes lacked new supporting data.
The concept of shared decisionmaking originated in the 1980s as a response to paternalistic medicine. It was intended for complex cases where treatment options are uncertain, not for routine vaccinations with established benefits.
Jake Scott, an infectious disease physician at Stanford, explains the broader implications: “Individual choices aggregate into population outcomes.” Declining vaccination rates impact not only the unvaccinated but also vulnerable populations like infants and immunocompromised individuals. The CDC previously applied shared decisionmaking only to the meningococcal B vaccine in 2015, as it protects only the recipient and does not prevent transmission.
Katherine Hall Jamieson, a misinformation researcher at the University of Pennsylvania, notes that the reframing of shared decisionmaking sows confusion. Surveys show that some people now believe it means vaccines are not beneficial for everyone. This misinterpretation also reinforces the false narrative that the CDC forces vaccinations. In reality, states determine school entry requirements, and parents can opt out, with exemption rates rising to 3.6% in 2024–25, up from 2.5% in 2019–20.
Scott warns that shared decisionmaking is being used as a political tool to weaken vaccine uptake without outright prohibition. The recent changes are likely not the last, suggesting a broader effort to degrade public health infrastructure under the guise of patient autonomy.
This shift in CDC policy raises critical questions about the long-term impact on herd immunity and public trust in medical science. The deliberate reframing of shared decisionmaking as a tool rather than a genuine patient-centered approach undermines decades of established public health practice.
